Terms: = Leukemia AND CD79B, ENSG00000007312, 974, P40259, IGB, B29
193 results:
1. Targeted degradation of oncogenic BCR-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN.
Sun Y; Wang Y; Liu C; Huang Y; Long Q; Ju C; Zhang C; Chen Y
J Nanobiotechnology; 2024 May; 22(1):247. PubMed ID: 38741123
[TBL] [Abstract] [Full Text] [Related]
2. Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial.
Budde LE; Olszewski AJ; Assouline S; Lossos IS; Diefenbach C; Kamdar M; Ghosh N; Modi D; Sabry W; Naik S; Mehta A; Nakhoda SK; Smith SD; Dorritie K; Jia T; Pham S; Huw LY; Jing J; Wu H; Ead WS; To I; Batlevi CL; Wei MC; Chavez JC
Nat Med; 2024 Jan; 30(1):229-239. PubMed ID: 38072960
[TBL] [Abstract] [Full Text] [Related]
3. Human cd79b
Meyer MA; Dinh HQ; Alimadadi A; Araujo DJ; Chatterjee N; Gutierrez NA; Zhu YP; Hunter EL; Liang S; Seumois G; Kiosses WB; Catz SD; Vijayanand P; Ottensmeier C; Hedrick CC
Front Immunol; 2023; 14():1224045. PubMed ID: 38022639
[TBL] [Abstract] [Full Text] [Related]
4. Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia.
Johnson PC; Woyach JA; Ulrich A; Marcotte V; Nipp RD; Lage DE; Nelson AM; Newcomb RA; Rice J; Lavoie MW; Ritchie CS; Bartlett N; Stephens DM; Ding W; Owen C; Stone R; Ruppert AS; Mandrekar SJ; Byrd JC; El-Jawahri A; Le-Rademacher J; Rosko A
J Geriatr Oncol; 2023 Jul; 14(6):101538. PubMed ID: 37329769
[TBL] [Abstract] [Full Text] [Related]
5. Optimizing Donor Chimerism Threshold for Next-Generation Sequencing Monitoring of Measurable Residual Disease Post-Allogeneic Stem Cell Transplantation for Myeloid Neoplasms.
Puzo CJ; Tormey CA; Rinder HM; Siddon AJ
Transplant Cell Ther; 2023 Jul; 29(7):459.e1-459.e4. PubMed ID: 37062510
[TBL] [Abstract] [Full Text] [Related]
6. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
Li W; Fang P; Fu G; Liang H; Peng M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
[TBL] [Abstract] [Full Text] [Related]
7. [Effects of Thiomersal on Apoptosis and Autophagy of leukemia Cell Lines].
Wang Y; Yao H; Li ZL; Yang K; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1655-1660. PubMed ID: 36476885
[TBL] [Abstract] [Full Text] [Related]
8. [Mutational features of immunoglobulin heavy chain variable region gene in patients with chronic lymphocytic leukemia].
Li YH; Huang XQ; Lin YN; Chen XJ; Chen L; Liu EB; Mi YC; Ru K
Zhonghua Bing Li Xue Za Zhi; 2022 Nov; 51(11):1135-1140. PubMed ID: 36323543
[No Abstract] [Full Text] [Related]
9. Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL.
Zhang T; Liu H; Jiao L; Zhang Z; He J; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Zhang H; Wang X
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35365585
[TBL] [Abstract] [Full Text] [Related]
10. Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders.
Mihályová J; Hradská K; Jelínek T; Motais B; Celichowski P; Hájek R
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768899
[TBL] [Abstract] [Full Text] [Related]
11. EIF3B Associates with Exacerbated Clinical Features, Poor Treatment Response and Survival in Adult Philadelphia Chromosome Negative Acute Lymphoblastic leukemia Patients.
Zhu F; Fu Y; He X
Technol Cancer Res Treat; 2021; 20():15330338211041464. PubMed ID: 34617851
[No Abstract] [Full Text] [Related]
12. Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance.
Chen JA; Hou Y; Roskin KM; Arber DA; Bangs CD; Baughn LB; Cherry AM; Ewalt MD; Fire AZ; Fresard L; Kearney HM; Montgomery SB; Ohgami RS; Pearce KE; Pitel BA; Merker JD; Gotlib J
Blood Adv; 2021 Sep; 5(17):3492-3496. PubMed ID: 34505882
[TBL] [Abstract] [Full Text] [Related]
13. Clinico-laboratory pertinences and management of relapsed and refractory.
Musteata V
J BUON; 2021; 26(3):1165-1168. PubMed ID: 34268985
[TBL] [Abstract] [Full Text] [Related]
14. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
[TBL] [Abstract] [Full Text] [Related]
15. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
Sciacchitano S; De Vitis C; D'Ascanio M; Giovagnoli S; De Dominicis C; Laghi A; Anibaldi P; Petrucca A; Salerno G; Santino I; Amodeo R; Simmaco M; Napoli C; Tafuri A; Di Napoli A; Sacconi A; Salvati V; Ciliberto G; Fanciulli M; Piaggio G; de Latouliere L; Ricci A; Mancini R
J Transl Med; 2021 Apr; 19(1):139. PubMed ID: 33794925
[TBL] [Abstract] [Full Text] [Related]
16. Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real-world evidence from the medicare population.
Goyal RK; Nagar SP; Kabadi SM; Le H; Davis KL; Kaye JA
Cancer Med; 2021 Apr; 10(8):2690-2702. PubMed ID: 33734606
[TBL] [Abstract] [Full Text] [Related]
17. The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.
Jalal SD
PLoS One; 2021; 16(2):e0247491. PubMed ID: 33606850
[TBL] [Abstract] [Full Text] [Related]
18. Impact of Physicians' Personalities and Behavioral Traits on Treatment-Related Decision-making for Elderly Acute Myeloid leukemia.
Wu X; Jiang YN; Zhang YL; Chen J; Mao YY; Zhang L; Zhou DB; Cao XX; Li J
J Gen Intern Med; 2021 Oct; 36(10):3023-3030. PubMed ID: 33511569
[TBL] [Abstract] [Full Text] [Related]
19. Downregulation of Lymphoid enhancer-binding factor 1 (LEF-1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic leukemia with atypical immunophenotypic and cytologic features.
Soliman DS; Al-Kuwari E; Siveen KS; Al-Abdulla R; Chandra P; Yassin M; Nashwan A; Hilmi FA; Taha RY; Nawaz Z; El-Omri H; Mateo JM; Al-Sabbagh A
Int J Lab Hematol; 2021 Jun; 43(3):515-525. PubMed ID: 33314668
[TBL] [Abstract] [Full Text] [Related]
20. Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors.
Zhang JW; Wang H; Liu J; Ma L; Hua RH; Bu ZG
Virol Sin; 2021 Jun; 36(3):476-489. PubMed ID: 33231855
[TBL] [Abstract] [Full Text] [Related]
[Next]